dc.creatorIglesias Molli, Andrea Elena
dc.creatorPanero, Julieta
dc.creatorDos Santos, Patricia Carolina
dc.creatorGonzález, Claudio Daniel
dc.creatorVilariño, Jorge
dc.creatorSereday, Marta
dc.creatorCerrone, Gloria Edith
dc.creatorSlavutsky, Irma Rosa
dc.creatorFrechtel, Gustavo Daniel
dc.date.accessioned2018-04-17T16:45:10Z
dc.date.available2018-04-17T16:45:10Z
dc.date.created2018-04-17T16:45:10Z
dc.date.issued2017-04
dc.identifierIglesias Molli, Andrea Elena; Panero, Julieta; Dos Santos, Patricia Carolina; González, Claudio Daniel; Vilariño, Jorge; et al.; Metabolically healthy obese women have longer telomere length than obese women with metabolic syndrome; Public Library of Science; Plos One; 12; 4; 4-2017; 1-13
dc.identifier1932-6203
dc.identifierhttp://hdl.handle.net/11336/42271
dc.identifier1932-6203
dc.identifierCONICET Digital
dc.identifierCONICET
dc.description.abstractIntroduction: Obesity is the principal component in the Metabolic Syndrome (MetS) that determines the progression of metabolic complications. Metabolically healthy obese (MHO) individuals seem to be protected against those complications. Telomere length (TL) as a novel marker of cellular aging had a complex relationship to the MetS. The principal aim of this study was to investigate the TL in MHO, and to study the association between TL and the worsening of the metabolic condition. Material and methods: We have determined the absolute TL (aTL) in 400 women (mean age of 46.76 - 15.47 years; range: 18-86 years), grouped according to the metabolic condition in three groups: metabolically healthy non-obese women (MHNO), MHO and obese women with MetS (MSO); and grouped according to the number of components of MetS. Results: We found that MHO displays significantly higher aTL than MSO (p = 0.033; r = -4.63; 95% CI r = -8.89 / -0.37), but did not differ from MHNO. A decrease in aTL with the progressive increase in the number of MetS components was also observed (p = 0.001; r = -2.06; 95% CI r = -3.13 / -0.99). In this way, our results indicate that aTL is influenced by the presence of MetS, but it is not affected by the presence of obesity. Discussion: We found that shorter aTL is not associated with MHO, but is related to MetS and with the increased number of metabolic abnormalities.
dc.languageeng
dc.publisherPublic Library of Science
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1371/journal.pone.0174945
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174945
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMETABOLIC SYNDROME (METS)
dc.subjectMETABOLICALLY HEALTHY OBESE (MHO)
dc.subjectMETABOLICALLY HEALTHY NON-OBESE WOMEN (MHNO)
dc.subjectOBESE WOMEN WITH METS (MSO)
dc.subjectTELOMERE LENGTH (TL)
dc.titleMetabolically healthy obese women have longer telomere length than obese women with metabolic syndrome
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución